For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Schrodinger Inc’s stock clocked out at $17.2, down -1.15% from its previous closing price of $17.4. In other words, the price has decreased by -$1.15 from its previous closing price. On the day, 0.96 million shares were traded. SDGR stock price reached its highest trading level at $17.68 during the session, while it also had its lowest trading level at $17.066.
Ratios:
To gain a deeper understanding of SDGR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.25 and its Current Ratio is at 3.25. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.29.
On September 30, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $19.
Citigroup Downgraded its Buy to Neutral on August 15, 2025, while the target price for the stock was maintained at $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 16 ’25 when Dugan Margaret sold 1,395 shares for $21.07 per share. The transaction valued at 29,387 led to the insider holds 24,574 shares of the business.
Dugan Margaret bought 1,395 shares of SDGR for $29,387 on Oct 16 ’25. On Apr 14 ’25, another insider, Akinsanya Karen, who serves as the President of R&D, Therapeutics of the company, sold 16,723 shares for $25.09 each. As a result, the insider received 419,570 and left with 15,625 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SDGR now has a Market Capitalization of 1267032960 and an Enterprise Value of 987345920. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.93 while its Price-to-Book (P/B) ratio in mrq is 3.94. Its current Enterprise Value per Revenue stands at 3.843 whereas that against EBITDA is -6.017.
Stock Price History:
The Beta on a monthly basis for SDGR is 1.53, which has changed by -0.10493827 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, SDGR has reached a high of $28.47, while it has fallen to a 52-week low of $15.99. The 50-Day Moving Average of the stock is -8.70%, while the 200-Day Moving Average is calculated to be -17.27%.
Shares Statistics:
It appears that SDGR traded 1.06M shares on average per day over the past three months and 787770 shares per day over the past ten days. A total of 64.47M shares are outstanding, with a floating share count of 62.74M. Insiders hold about 14.83% of the company’s shares, while institutions hold 96.21% stake in the company. Shares short for SDGR as of 1764288000 were 10329983 with a Short Ratio of 9.74, compared to 1761868800 on 9822256. Therefore, it implies a Short% of Shares Outstanding of 10329983 and a Short% of Float of 25.540000000000003.
Earnings Estimates
The firm’s stock currently is rated by 2.0 analysts. The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.39 and low estimates of -$0.62.
Analysts are recommending an EPS of between -$1.94 and -$2.11 for the fiscal current year, implying an average EPS of -$2.03. EPS for the following year is -$1.1, with 2.0 analysts recommending between -$0.98 and -$1.22.
Revenue Estimates
In. The current quarter, 8 analysts expect revenue to total $83.22M. It ranges from a high estimate of $86.27M to a low estimate of $81.1M. As of. The current estimate, Schrodinger Inc’s year-ago sales were $88.32MFor the next quarter, 8 analysts are estimating revenue of $72.55M. There is a high estimate of $78.76M for the next quarter, whereas the lowest estimate is $67.1M.
A total of 9 analysts have provided revenue estimates for SDGR’s current fiscal year. The highest revenue estimate was $254.91M, while the lowest revenue estimate was $249.74M, resulting in an average revenue estimate of $251.72M. In the same quarter a year ago, actual revenue was $207.54MBased on 9 analysts’ estimates, the company’s revenue will be $303.17M in the next fiscal year. The high estimate is $395.98M and the low estimate is $274.8M.
